外科医のアロジェニック幹細胞移植を受ける患者の長期滞在に関連する要因
Edward Koo1, Connor Prince1, David Allan1
1Transplant and Cellular Therapy Program, Division of Hematology, Department of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, CA.
Transplantation and cellular therapy
|February 14, 2026
まとめ
外科の全種性造血性幹細胞移植 (HCT) は安全で実行可能で,入院日数も節約できます. 女性の性別,低ヘモグロビン,および特定の移植因子は,より長い入院滞在を予測し,資源管理を支援します.
科学分野:
- 血液学 ヘマトロジ
- 移植医療 移植医療について
- 腫瘍学 腫瘍学
背景:
- アロゲン性血液形成性幹細胞移植 (HCT) は,外科医の診療でますます行われています.
- アロゲン性HCT患者さんの長時間入院に影響を与える要因に関するデータは限られている.
研究 の 目的:
- 外来診療の昼間の病院モデル内で,アレルゲン性HCTを受ける患者の長期滞在と関連したパラメータを特定する.
主な方法:
- 213人の患者で,野外治療のアルジェニックHCT (2021年7月〜2024年7月) を受けた患者の遡及的分析.
- マン・ホイットニーUとChi-squaredテストは,単変数解析のためのものです.
- 多変量分析のためのバイナリロジスティック回帰で,5日以上の入院に関連する要因を特定します.
主要な成果:
- 女性の性別,移植前ヘモグロビン<100g/L,HCT-CI>2,非フルダラビン/ブスルファン条件付け療法,およびABO不一致は,長期の入院と関連していました.
- 患者の13.3%は入院なし,50.7%は入院1回でした.
- 患者"人当たりの入院ベッドデイ平均22日間の節約が観察されました.
結論:
- 昼間の病院モデルによる野外的な全遺伝性HCTは,実行可能で費用対効果の高いアプローチです.
- 長期入院の原因となる要因を特定することで,患者の教育とリソースの配置が改善されます.
関連する概念動画
Induced Pluripotent Stem Cells
28.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.2K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
354
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
354
Adult Stem Cells
33.9K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Embryonic Stem Cells
32.7K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.7K
Embryonic Stem Cells
5.3K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.3K
Transcription Factors
82.9K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.9K


